Regulatory risk, lengthy product development timelines, capital intensive, long sales cycles and slow market adoption are just a few of the reasons why angels avoid investing in medical device startups.  A key leader on acquisitions for big players such as Medtronic and Covidien, Dave Giarracco will share with fellow angel investors what it takes for medical device companies to win big and how angels can diligence whether the risk is worth the potential reward. 

Speakers:  Dave Giarracco, Rockies Venture Club

Presentation Materials

Access the Recording